Redefining Early Stage Investments (RESI)

Vienna Marriott Hotel

Parkring 12a, Vienna 1010, Austria

Monday 25 March 2019

07:00 - 19:00

RESI is a premier international conference that provides an opportunity for early-stage life science companies across Drugs, Devices, Diagnostics & Digital Health, to source investors from around the globe, create relationships, and potentially, secure funding.
Investor
Photo: Andrey Popov/Most Photos

The basic RESI format is unique in that it is held regularly every few months (an industry first) and gives both fundraising CEOs and early-stage investor/partners a capability to use RESI as part of their ongoing business activities. 

Scientist/entrepreneurs can weave themselves into the RESI conference series and dramatically increase face time with prime partnering targets. 

What you can expect:
•    Full-day partnering conference with custom-built partnering system tailored to the early stage life science arena 
•    Up to 16 scheduled meetings per attendee 
•    In-depth panels featuring speakers from 10 categories of early stage investors 
•    RESI Innovation Challenge and Entrepreneurs workshops.
•    Exhibtion

Färgbox

Discount code for West Swedish companies: GOTEBORG for guaranteed early bird pricing of EUR 995 (+ VAT).

Who attends (700-1000+ attendees)

Investors

  • Large Pharma/Medtech    23%
  • Venture Capital     20%
  • Family Office/Private Wealth    14%
  • Corporate Venture Capital    13%
  • Angel     10%
  • Government Organization    7%
  • Private Equity    5%
  • Endowment/Foundation    3%
  • Institutional Alternative Investor    3%
  • Hedge Fund    2%

Innovators

  • Therapeutics    
  • Medical Device    
  • Diagnostics    
  • HealthcareIT    

Tip a friend